23andMe Holding Co (NAS:ME) Stock News, Headlines & Updates
23andMe Holding Co Stock News from GuruFocus
- 1
Jun 28, 2024
23andMe And Nightingale Health Announce Strategic Collaboration To Pilot Blood Biomarker Panel
Marketwired • 6:00am
Jun 05, 2024
23andMe Launches New Genetic Report on Bipolar Disorder
Marketwired • 6:00am
Jun 04, 2024
23andMe and the Colorectal Cancer Alliance Collaborate to Help Advance Colorectal Cancer Research in the Black Community
Marketwired • 6:00am
Jun 03, 2024
23andMe Therapeutics Announces Positive Preliminary Phase 2 Safety and Efficacy Results for 23ME-00610, targeting CD200R1, at the 2024 ASCO Annual Meeting
Marketwired • 7:00am
May 29, 2024
Largest study on the LRRK2 variant leads to discoveries about health, ancestry, and history
Marketwired • 7:00am
May 24, 2024
23andMe Holding Co (ME) Q4 2024 Earnings Call Transcript Highlights: Navigating Revenue Declines and Strategic Shifts
GuruFocus Research • 1:02am
Q4 2024 23andMe Holding Co. Earnings Call Transcript
GuruFocus Research • 11:07pm
May 23, 2024
23andMe (ME) Q4 FY24 Earnings: Revenue Beats Estimates Despite 31% YoY Decline, EPS Misses Expectations
GuruFocus Research • 3:32pm
May 14, 2024
Lemonaid Health Now Offers Prescription ED Medication STENDRA? Through Collaboration with Petros Pharmaceuticals
Marketwired • 6:00am
May 09, 2024
23andMe to Report Q4 and Full Year FY2024 Financial Results
Marketwired • 4:00pm
Apr 30, 2024
Potter Handy Law Firm Represents Nearly 5,000 Clients in 23andMe Data Breach Case
Business Wire • 11:00am
Apr 24, 2024
23andMe to Present Preliminary Efficacy and Biomarker Data for 23ME-00610 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Marketwired • 4:00pm
Apr 18, 2024
23andMe announces CEO's intention to pursue a potential take-private
Marketwired • 7:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news